9th Dec 2020 21:07
Creo Medical Group PLC - medical device company headquartered in Chepstow, Wales - Notes first in-man clinical use of its MicroBlate Fine device, which is the world's smallest fine needle microwave ablation device available for clinical practice.
Device is used to successfully ablate pancreatic tumour tissue under endoscopic ultrasound guidance.
"We are very pleased with the first in-man clinical use of the MicroBlate Fine device, bringing fine needle microwave ablation into clinical practice for the first time and in particular, as in this case, in the hands of GI physicians," said Chief Executive Officer Craig Gulliford.
Current stock price: 200.00 pence; up 20% on Wednesday
Year-to-date change: up 10%
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Creo Medical